Afmidtm1b/+ heterozygous male mice were tested at 16 and 28 weeks and exhibited mild impaired glucose tolerance with significantly elevated glucose levels at 60 and 120 min at 16 weeks and at 60 min at 28 weeks compared to Afmid+/+ controls (Fig. 3C,E). Here, AFMID is linked to Impaired glucose tolerance.